Karine Dube

Title(s)Associate Adjunct Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
ORCID ORCID Icon0000-0003-3458-1539 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UNC Gillings School of Global Public Health, Chapel Hill, NC, USADrPH05/2016Health Policy and Management (HPM)
    Oxford University, Oxford, EnglandMPhil07/2005Development Studies/International Health
    University of North Carolina at Chapel Hill, Chapel Hill, NC, USABA05/2003International Studies (Global Health)/Business Administration
    Collapse Awards and Honors
    UNC Gillings School of Global Public Health2015Arthur B. Holzworth Endowed Scholarship in Health Leadership
    Queen Elizabeth House, Oxford University2005Distinction
    Oxford University2003  - 2005Rhodes Scholarship
    University of North Carolina at Chapel Hill2003Robert E. Bryan Service Award
    University of North Carolina at Chapel Hill2003Order of the Old Well
    University of North Carolina at Chapel Hill2002Jane Craig Gray Memorial Award
    University of North Carolina at Chapel Hill2002Order of the Golden Fleece
    University of North Carolina at Chapel Hill2001Order of the Grail-Valkyries
    University of North Carolina at Chapel Hill1999  - 2003Morehead Scholarship

    Collapse Overview 
    Collapse Overview
    Dr. Dubé is a senior socio-behavioral scientist and experienced research program manager who integrates biomedical, social sciences, ethics and patient engagement around HIV-related research in the United States and South Africa. She has close to 20 years of experience in infectious disease-related work, including the socio-behavioral sciences and ethics of HIV cure-related research, HIV prevention, HIV treatment, Ebola, malaria and HSV-2.

    She is the Multi-Principal Investigator of a National Institute of Mental Health (NIMH) R01 grant investigating psychosocial experiences of people with HIV who interrupt treatment during cure research as part of the AIDS Clinical Trials Group (ACTG) and at the University of California San Francisco (UCSF) (with Dr. John Sauceda, UCSF). She completed a R21-NIMH grant (as Principal Investigator/Project Director) that integrated participant-centered outcomes and socio-behavioral assessments in clinical trials in the ACTG. She is the lead socio-behavioral researcher and bioethicist on the University of California San Diego (UCSD) Last Gift program (http://lastgift.ucsd.edu/). She also consults for and has consulted with several groups on socio-behavioral sciences related to HIV cure research, notably the BEAT-HIV Collaboratory (Wistar Institute), RID-HIV Collaboratory (Scripps Research Institute), the amfAR Institute for HIV Cure Research and Delaney AIDS Research Enterprise (DARE) Collaboratory, the City of Hope/California Institute of Regenerative Medicine (CIRM), and the Ragon Institute of MGH, MIT and Harvard.

    Dr. Dubé served as Co-Investigator on the Social and Ethical Aspects of Curing HIV Infection (searcHIV) working group at UNC Chapel Hill from 2014 – 2017. She also served as Research Program Manager for the Collaboratory of AIDS Researchers for Eradication (CARE) at UNC-Chapel Hill from 2013 – 2015. She led willingness to participate research in HIV cure in the United States. She is co-founder and co-leader of the CUREiculum (https://www.treatmentactiongroup.org/cure/cureiculum-2-0/), a collaborative program aimed at making HIV cure science accessible to the community and the HIV research field.

    In 2016, she managed the UNC-CH - ClinicalRM - ELWA Ebola consortium. She led a vaccine cohort development program, two HIV-1C prospective incidence studies and a clinical research site capacity development effort in Maputo, Beira and Chókwè, Mozambique with the United States Military HIV Research Program (MHRP)/Walter Reed Army Institute of Research/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) and FHI 360.

    Collapse Research 
    Collapse Research Activities and Funding
    Clinical, Outreach, Pathology and Ethics (COPE) Core of Leaving, Coming and Staying HIV Obligate Microenvironments (HOME)
    NIAID P01AI169609Oct 1, 2022 - Mar 31, 2027
    Role: Core Co-Lead (with Susan Little), Lead Socio-Behavioral Scientist/Bioethicist
    Site Preparedness Activities for Research on Post-Intervention Control of HIV in Durban, South Africa
    Gilead Public Affairs Mar 31, 2022 - Feb 28, 2023
    Role: Principal Investigator/Co-Project Director
    Investigating Psychosocial Experiences of HIV Cure Trial Participants Undergoing Extended HIV Treatment Interruptions: Implications for Ethical Conduct
    NIMH R01-MH126768Sep 1, 2021 - Aug 31, 2026
    Role: MPI
    BEAT-HIV Delaney Collaboratory Social Sciences and Ethics Working Group
    NIAID UM1 AI164570Apr 1, 2021 - Mar 31, 2026
    Role: Co-Investigator/Socio-Behavioral Scientist
    A Pilot Study to Evaluate Alternative Viral Load Tests during Analytical Treatment Interruptions in HIV Cure-Directed Trials: Reliability and Acceptability of Home Test Measures
    Merck & Co, Inc. Jul 1, 2020 - Sep 30, 2022
    Role: Co-Investigator
    Ethics Administrative Supplement: Advancing Empirical Research Ethics for HIV Cure Research
    NIMH Ethics Supplement to R21-MH118120May 6, 2020 - Sep 30, 2022
    Role: Principal Investigator
    Perceptions of Risks and Benefits of Participating in HIV Cure-Related Research among Diverse Youth and Young Adults Living with HIV in the United States
    NIMH R21-MH122280May 1, 2020 - Apr 30, 2022
    Role: MPI
    Social Sciences in HIV Combination Trial
    amfAR Institute for HIV Cure Research 10931May 23, 2019 - Dec 31, 2021
    Role: MPI
    Pilot Integration of Participant-Centered Outcomes in HIV Cure Research in the United States: Implications for Ethical Conduct
    NIMH R21-MH118120May 1, 2019 - Sep 30, 2022
    Role: PI/PD
    Social Sciences of HIV Cure Research in the United States
    Gilead Public Affairs Jul 1, 2017 - Jul 31, 2017
    Role: Consultant (Protocol Principal Investigator)
    Social and Ethical Implications of HIV Cure Research (searcHIV)
    NIAID R01 AI08366Feb 2, 2017 - Sep 14, 2017
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Preferences for HIV Treatment Formulations among Young Adults with HIV in the United States. J Acquir Immune Defic Syndr. 2022 Nov 07. Saberi P, Stoner MCD, Eskaf S, Ndukwe S, Campbell CK, Sauceda JA, Dubé K. PMID: 36343377.
      View in: PubMed   Mentions:
    2. Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program. Curr HIV/AIDS Rep. 2022 Oct 19. Riggs PK, Chaillon A, Jiang G, Letendre SL, Tang Y, Taylor J, Kaytes A, Smith DM, Dubé K, Gianella S. PMID: 36260191.
      View in: PubMed   Mentions:
    3. Willingness of Racially Diverse Young Adults Living with HIV to Participate in HIV Cure Research: A Cross-Sectional Survey in the United States. AIDS Res Hum Retroviruses. 2022 Oct 13. Dube K, Campbell C, Eskaf S, Sauceda JA, Ndukwe SO, Henley L, Persaud D, Deeks SG, Auerbach JD, Saberi P. PMID: 36226414.
      View in: PubMed   Mentions:
    4. Overcoming Challenges of Online Research: Measures to Ensure Enrollment of Eligible Participants. J Acquir Immune Defic Syndr. 2022 Oct 01; 91(2):232-236. Campbell CK, Ndukwe S, Dubé K, Sauceda JA, Saberi P. PMID: 36094490.
      View in: PubMed   Mentions:
    5. Health Care Bias and Discrimination Experienced by Lesbian, Gay, Bisexual, Transgender, and Queer Parents of Children With Developmental Disabilities: A Qualitative Inquiry in the United States. J Pediatr Health Care. 2022 Sep 29. Coulter-Thompson EI, Matthews DD, Applegate J, Broder-Fingert S, Dubé K. PMID: 36184374.
      View in: PubMed   Mentions:
    6. "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption. AIDS Res Hum Retroviruses. 2022 Sep 15. Neergaard R, Jones NL, Roebuck C, Rendle KA, Barbati Z, Peterson B, Tebas P, Mounzer K, Metzger D, Montaner LJ, Dube K, Barg FK. PMID: 35979886.
      View in: PubMed   Mentions:
    7. "I Would Absolutely Need to Know That My Partner Is Still Going to be Protected": Perceptions of HIV Cure-Related Research Among Diverse HIV Serodifferent Couples in the United States. AIDS Res Hum Retroviruses. 2022 Sep 08. Dubé K, Agarwal H, Stockman JK, Auerbach JD, Sauceda JA, Conroy AA, Johnson MO. PMID: 35972752.
      View in: PubMed   Mentions:
    8. "In diversity there is beauty and there is strength." -Dr. Maya Angelou A Community Call to Action to Prioritize Inclusion and Enrollment of Women in HIV Cure-Related Research. J Acquir Immune Defic Syndr. 2022 Sep 02. Campbell DM, Cowlings PD, Tholanah M, Robinson MJ, Graham G, Aseru S, Dubé K, Cohn SE, Bar KJ, Connick E, Mngqbisa R, Scully EP, Stockman JK, Gianella S. PMID: 36083494.
      View in: PubMed   Mentions:
    9. Participant experiences using novel home-based blood collection device for viral load testing in the HIV cure trials with analytical treatment interruptions. HIV Res Clin Pract. 2022 Aug 02; 23(1):76-90. Dubé K, Agarwal H, Carter WB, Dee L, Taylor J, Roebuck C, Peterson B, Patel H, Ndukwe S, Lynn KM, Lalley-Chareczko L, Hiserodt E, Kim S, Rosenbloom D, Evans BR, Anderson M, Hazuda DJ, Bateman K, Howell BJ, Azzoni L, Mounzer K, Tebas P, Montaner LJ. PMID: 35968737; PMCID: PMC9403870.
      View in: PubMed   Mentions:
    10. Willingness of Older Canadians with HIV to Participate in HIV Cure Research Near and After the End of Life: A Mixed-Method Study. AIDS Res Hum Retroviruses. 2022 Aug; 38(8):670-682. Lessard D, Dubé K, Bilodeau M, Keeler P, Margolese S, Rosenes R, Sinyavskaya L, Durand M, Benko E, Kovacs C, Guerlotté C, Tharao W, Arnold K, Masching R, Taylor D, Sousa J, Ostrowski M, Taylor J, Kaytes A, Smith D, Gianella S, Chomont N, Angel JB, Routy JP, Cohen ÉA, Lebouché B, Costiniuk CT. PMID: 35778845; PMCID: PMC9483839.
      View in: PubMed   Mentions:    Fields:    
    11. Exploration of a Mobile Technology Vulnerability Scale's association with antiretroviral adherence among young adults living with HIV in the United States. Mhealth. 2022; 8:23. Saberi P, Eskaf S, Campbell CK, Neilands TB, Sauceda JA, Dubé K. PMID: 35928514; PMCID: PMC9343971.
      View in: PubMed   Mentions:
    12. Community HIV clinicians' perceptions about HIV cure-related research in the Northwestern United States. HIV Res Clin Pract. 2022 Jul 18; 23(1):61-75. Sylla L, Patel H, Louella M, Simoni J, Dubé K. PMID: 35904107.
      View in: PubMed   Mentions:    Fields:    
    13. "It comes altogether as one:" perceptions of analytical treatment interruptions and partner protections among racial, ethnic, sex and gender diverse HIV serodifferent couples in the United States. BMC Public Health. 2022 07 09; 22(1):1317. Campbell DM, Dubé K, Cowlings PD, Dionicio P, Tam RM, Agarwal H, Stockman JK, Auerbach JD, Sauceda JA, Conroy AA, Johnson MO. PMID: 35810288; PMCID: PMC9270765.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. It's Time to Embed Health-related Quality of Life across all Steps of the HIV Care Cascade. J Acquir Immune Defic Syndr. 2022 Jun 30. Arora AK, Lessard D, Dubé K, Lebouché B. PMID: 35916884.
      View in: PubMed   Mentions:
    15. Perceptions of Risks and Benefits of Participating in HIV Cure-Related Research Among Diverse Young Adults Living with HIV in the United States: Qualitative Research Findings. AIDS Res Hum Retroviruses. 2022 Aug; 38(8):649-659. Saberi P, Campbell CK, Sauceda JA, Ndukwe S, Dubé K. PMID: 35579937; PMCID: PMC9464049.
      View in: PubMed   Mentions:    Fields:    
    16. Lessons learned from the Last Gift study: ethical and practical challenges faced while conducting HIV cure-related research at the end of life. J Med Ethics. 2022 Jun 22. Kanazawa J, Rawlings SA, Hendrickx S, Gianella S, Concha-Garcia S, Taylor J, Kaytes A, Patel H, Ndukwe S, Little SJ, Smith D, Dubé K. PMID: 35732421.
      View in: PubMed   Mentions:    Fields:    
    17. Sustainability of Funding for HIV Treatment Services: A Cross-Sectional Survey of Patients' Willingness to Pay for Treatment Services in Nigeria. Glob Health Sci Pract. 2022 04 28; 10(2). Durosinmi-Etti O, Fried B, Dubé K, Sylvia S, Greene S, Ikpeazu A, Nwala EK. PMID: 35487556; PMCID: PMC9053145.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause in the United States: Results from the AIDS Clinical Trials Group A5345 Biomarker Study. AIDS Res Hum Retroviruses. 2022 06; 38(6):510-517. Dubé K, Eskaf S, Barr L, Palm D, Hogg E, Simoni JM, Sugarman J, Brown B, Sauceda JA, Henley L, Deeks S, Fox L, Gandhi RT, Smith D, Li JZ. PMID: 35323030; PMCID: PMC9225827.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    19. Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States. BMC Med Ethics. 2022 04 09; 23(1):39. Dubé K, Kanazawa J, Patel H, Louella M, Sylla L, Sheehy J, Dee L, Taylor J, Adair J, Anthony-Gonda K, Dropulic B, Sauceda JA, Peluso MJ, Deeks SG, Simoni J. PMID: 35397551; PMCID: PMC8994300.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Attitudes Toward Payment for Research Participation: Results from a U.S. Survey of People Living with HIV. AIDS Behav. 2022 Oct; 26(10):3267-3278. Polonijo AN, Dubé K, Galea JT, Greene KY, Taylor J, Christensen C, Brown B. PMID: 35386050; PMCID: PMC9474466.
      View in: PubMed   Mentions:    Fields:    
    21. "We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States. HIV Res Clin Pract. 2022 Mar 29; 1-16. Dubé K, Kanazawa J, Roebuck C, Johnson S, Carter WB, Dee L, Peterson B, Lynn KM, Lalley-Chareczko L, Hiserodt E, Kim S, Rosenbloom D, Evans BR, Anderson M, Hazuda DJ, Shipley L, Bateman K, Howell BJ, Mounzer K, Tebas P, Montaner LJ. PMID: 35348047; PMCID: PMC9519804.
      View in: PubMed   Mentions:    Fields:    
    22. SARS-CoV-2 Booster Vaccination for Participants in "HIV Cure"-Related Clinical Trials. J Acquir Immune Defic Syndr. 2022 03 01; 89(3):e30. Peluso MJ, Williams MC, Campbell DM, Dee L, Taylor J, Ngo LH, Hoh R, Dubé K, Sauceda JA, Deeks SG. PMID: 35147584; PMCID: PMC8851852.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    23. Editorial: Critical social and behavioral sciences perspectives on ending the HIV epidemic. Curr Opin HIV AIDS. 2022 03 01; 17(2):37-39. Auerbach JD, Dubé K. PMID: 35225247; PMCID: PMC8983018.
      View in: PubMed   Mentions:    Fields:    
    24. Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States. J Pers Med. 2022 Feb 07; 12(2). Dubé K, Eskaf S, Hastie E, Agarwal H, Henley L, Roebuck C, Carter WB, Dee L, Taylor J, Mapp D, Campbell DM, Villa TJ, Peterson B, Lynn KM, Lalley-Chareczko L, Hiserodt E, Kim S, Rosenbloom D, Evans BR, Anderson M, Hazuda DJ, Shipley L, Bateman K, Howell BJ, Mounzer K, Tebas P, Montaner LJ. PMID: 35207719; PMCID: PMC8879991.
      View in: PubMed   Mentions: 1  
    25. Ethical and practical considerations for HIV cure-related research at the end-of-life: a qualitative interview and focus group study in the United States. BMC Med Ethics. 2022 01 11; 23(1):2. Kanazawa J, Gianella S, Concha-Garcia S, Taylor J, Kaytes A, Christensen C, Patel H, Ndukwe S, Rawlings SA, Hendrickx S, Little S, Brown B, Smith D, Dubé K. PMID: 35012544; PMCID: PMC8748179.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Bringing social context into global biomedical HIV cure-related research: An urgent call to action. J Virus Erad. 2022 Mar; 8(1):100062. Miall A, McLellan R, Dong K, Ndung'u T, Saberi P, Sauceda JA, Dubé K. PMID: 35169489; PMCID: PMC8829132.
      View in: PubMed   Mentions:
    27. Ethical considerations for HIV remission clinical research involving participants diagnosed during acute HIV infection. BMC Med Ethics. 2021 12 28; 22(1):169. Gilbertson A, Tucker JD, Dubé K, Dijkstra M, Rennie S. PMID: 34961509; PMCID: PMC8714439.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Illustrating HIV Cure Research Strategies for the Next Generation of Research Participants: A Research-Community Collaboration. AIDS Res Hum Retroviruses. 2022 01; 38(1):5-10. Saberi P, Campbell CK, Lee EY, Guzman J, McCormack-Sharp MM, Dubé K. PMID: 34779679; PMCID: PMC8785759.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Evaluating the Impact of Incentives on Clinical Trial Participation: Protocol for a Mixed Methods, Community-Engaged Study. JMIR Res Protoc. 2021 Nov 23; 10(11):e33608. Galea JT, Greene KY, Nguyen B, Polonijo AN, Dubé K, Taylor J, Christensen C, Zhang Z, Brown B. PMID: 34817381; PMCID: PMC8663586.
      View in: PubMed   Mentions:
    30. Antiretroviral therapy experience, satisfaction, and preferences among a diverse sample of young adults living with HIV. AIDS Care. 2022 Sep; 34(9):1212-1218. Campbell CK, Dubé K, Sauceda JA, Ndukwe S, Saberi P. PMID: 34793253; PMCID: PMC9114167.
      View in: PubMed   Mentions:    Fields:    
    31. Considerations for designing and implementing combination HIV cure trials: findings from a qualitative in-depth interview study in the United States. AIDS Res Ther. 2021 10 18; 18(1):75. Dubé K, Kanazawa J, Dee L, Taylor J, Sauceda JA, Gianella S, Smith D, Deeks SG, Peluso MJ. PMID: 34663375; PMCID: PMC8522863.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI). Gene Ther. 2021 Sep 29. Adair JE, Androski L, Bayigga L, Bazira D, Brandon E, Dee L, Deeks S, Draz M, Dubé K, Dybul M, Gurkan U, Harlow E, Kityo C, Louella M, Malik P, Mathews V, McKemey A, Mugerwa H, Muyanja D, Olayiwola O, Orentas RJ, Popovski A, Sheehy J, Ssali F, Nsubuga MS, Tisdale JF, Verhoeyen E, Dropulic B. PMID: 34584245.
      View in: PubMed   Mentions:    Fields:    
    33. Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI). Gene Ther. 2021 Sep 08. Adair JE, Androski L, Bayigga L, Bazira D, Brandon E, Dee L, Deeks S, Draz M, Dubé K, Dybul M, Gurkan U, Harlow E, Kityo C, Louella M, Malik P, Mathews V, McKemey A, Mugerwa H, Muyanja D, Olayiwola O, Orentas RJ, Popovski A, Sheehy J, Ssali F, Nsubuga MS, Tisdale JF, Verhoeyen E, Dropulic B. PMID: 34493840.
      View in: PubMed   Mentions: 1     Fields:    
    34. SARS-CoV-2 Vaccination in the Context of Ongoing HIV Cure-Related Research Studies. J Acquir Immune Defic Syndr. 2021 08 01; 87(4):e232-e233. Peluso MJ, Dee L, Taylor J, Campbell DM, Ehm A, Agosto-Rosario M, Shao S, Williams MC, Hoh R, Rutishauser RL, Deeks SG, Sauceda JA, Dubé K. PMID: 33852502; PMCID: PMC8217209.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    35. Ethical and practical considerations for interventional HIV cure-related research at the end-of-life: A qualitative study with key stakeholders in the United States. PLoS One. 2021; 16(7):e0254148. Kanazawa J, Gianella S, Concha-Garcia S, Taylor J, Kaytes A, Christensen C, Patel H, Ndukwe S, Rawlings S, Hendrickx S, Little S, Brown B, Smith D, Dubé K. PMID: 34270612; PMCID: PMC8284787.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. Ethics of HIV cure research: an unfinished agenda. BMC Med Ethics. 2021 06 30; 22(1):83. Dubé K, Kanazawa J, Taylor J, Dee L, Jones N, Roebuck C, Sylla L, Louella M, Kosmyna J, Kelly D, Clanton O, Palm D, Campbell DM, Onaiwu MG, Patel H, Ndukwe S, Henley L, Johnson MO, Saberi P, Brown B, Sauceda JA, Sugarman J. PMID: 34193141; PMCID: PMC8243312.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Impact of dedicated women's outreach workers (WOWs) on recruitment of women in ACTG clinical studies. HIV Res Clin Pract. 2021 04; 22(2):37-45. Barr E, Dubé K, Swaminathan S, Del Rio C, Campbell DM, Paez-Quinde M, Cohn SE. PMID: 34143949; PMCID: PMC8496343.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry. AIDS Res Hum Retroviruses. 2022 01; 38(1):50-63. Dubé K, Kanazawa J, Campbell C, Boone CA, Maragh-Bass AC, Campbell DM, Agosto-Rosario M, Stockman JK, Diallo DD, Poteat T, Johnson M, Saberi P, Sauceda JA. PMID: 33947268; PMCID: PMC8785755.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    39. Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative Approach. Clin Infect Dis. 2021 05 18; 72(10):1843-1849. Peluso MJ, Dee L, Shao S, Taylor J, Campbell D, Collins S, Gandhi M, Johnston R, Deeks SG, Sauceda JA, Dubé K. PMID: 32841311; PMCID: PMC7499539.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
    40. Attitudes and perceptions of next-of-kin/loved ones toward end-of-life HIV cure-related research: A qualitative focus group study in Southern California. PLoS One. 2021; 16(5):e0250882. Javadi SS, Mathur K, Concha-Garcia S, Patel H, Perry KE, Lo M, Taylor J, Kaytes A, Little S, Gianella S, Smith D, Dubé K. PMID: 33961653; PMCID: PMC8104928.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Time to Engage Young People in HIV Cure Research. AIDS Res Hum Retroviruses. 2022 01; 38(1):2-4. Saberi P, Campbell CK, Venegas M, Dubé K. PMID: 33677996; PMCID: PMC8785756.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research. HIV Res Clin Pract. 2021 02; 22(1):14-30. Dubé K, Kanazawa J, Dee L, Taylor J, Campbell DM, Brown B, Johnson MO, Saberi P, Sauceda JA, Sugarman J, Peluso MJ. PMID: 33757411; PMCID: PMC8272285.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    43. Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study. AIDS Res Hum Retroviruses. 2021 06; 37(6):489-501. Diepstra KL, Barr L, Palm D, Hogg E, Mollan KR, Henley L, Stover AM, Simoni JM, Sugarman J, Brown B, Sauceda JA, Deeks S, Fox L, Gandhi RT, Smith D, Li JZ, Dubé K. PMID: 33472545; PMCID: PMC8213012.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    44. Comparing Payments Between Sociobehavioral and Biomedical Studies in a Large Research University in Southern California. J Empir Res Hum Res Ethics. 2021 Feb-Apr; 16(1-2):117-124. Brown B, Marg L, Michels E, Zhang Z, Kuzmanovic D, Dubé K, Galea JT. PMID: 33535867.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. "I would really want to know that they had my back": Transgender women's perceptions of HIV cure-related research in the United States. PLoS One. 2020; 15(12):e0244490. Poteat T, Aqil A, Corbett D, Evans D, Dubé K. PMID: 33382760; PMCID: PMC7774946.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    46. Framing a Consent Form to Improve Consent Understanding and Determine How This Affects Willingness to Participate in HIV Cure Research: An Experimental Survey Study. J Empir Res Hum Res Ethics. 2021 Feb-Apr; 16(1-2):78-87. Sauceda JA, Dubé K, Brown B, Pérez AE, Rivas CE, Evans D, Fisher CB. PMID: 33307932; PMCID: PMC8035136.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review. AIDS Res Hum Retroviruses. 2021 02; 37(2):75-88. Kanazawa JT, Saberi P, Sauceda JA, Dubé K. PMID: 33176429; PMCID: PMC8020525.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    48. Multi-stakeholder consensus on a target product profile for an HIV cure. Lancet HIV. 2021 01; 8(1):e42-e50. Lewin SR, Attoye T, Bansbach C, Doehle B, Dubé K, Dybul M, SenGupta D, Jiang A, Johnston R, Lamplough R, McCune JM, Nabel GJ, Ndung'u T, Pottage J, Ripin D, Rooney JF, Sikazwe I, Nsubuga M, Warren M, Deeks SG, Sunnylands 2019 Working Group. PMID: 33271125; PMCID: PMC7773628.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsPHPublic Health
    49. "[It] is now my responsibility to fulfill that wish:" Clinical and rapid autopsy staff members' experiences and perceptions of HIV reservoir research at the end of life. PLoS One. 2020; 15(11):e0242420. Perry KE, Taylor J, Patel H, Javadi SS, Mathur K, Kaytes A, Concha-Garcia S, Little S, Smith D, Gianella S, Dubé K. PMID: 33206710; PMCID: PMC7673534.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    50. Ethical Reflections on the Conduct of HIV Research with Community Members: A Case Study. J Empir Res Hum Res Ethics. 2021 Feb-Apr; 16(1-2):65-77. Brown B, Taylor J, Dubé K, Kuzmanovic D, Long Y, Marg L. PMID: 33174498.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Long-term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of Inflammation. Clin Infect Dis. 2020 10 23; 71(7):1749-1755. Tozay S, Fischer WA, Wohl DA, Kilpatrick K, Zou F, Reeves E, Pewu K, DeMarco J, Loftis AJ, King K, Grant D, Schieffelin J, Gorvego G, Johnson H, Conneh T, Williams G, Nelson JAE, Hoover D, McMillian D, Merenbloom C, Hawks D, Dube K, Brown J. PMID: 31693114; PMCID: PMC7755089.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsPHPublic Health
    52. Time for revolution? Enhancing meaningful involvement of people living with HIV and affected communities in HIV cure-focused science. J Virus Erad. 2020 Nov; 6(4):100018. Lau JSY, Smith MZ, Allan B, Dubé K, Young AT, Power J. PMID: 33251026; PMCID: PMC7646668.
      View in: PubMed   Mentions: 3  
    53. Re-examining the HIV 'functional cure' oxymoron: Time for precise terminology? J Virus Erad. 2020 Nov; 6(4):100017. Dubé K, Willenberg L, Dee L, Sylla L, Taylor J, Roebuck C, Palm D, Campbell D, Newton L, Patel H, Perry KE, Kanazawa J, Gerrard J, Brown B, Saberi P, Sauceda JA, Peluso MJ. PMID: 33251025; PMCID: PMC7646673.
      View in: PubMed   Mentions: 3  
    54. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options. AIDS Res Hum Retroviruses. 2020 12; 36(12):1054-1058. Dubé K, Campbell DM, Perry KE, Kanazawa JT, Saberi P, Sauceda JA, Poteat T, Evans D. PMID: 32829645; PMCID: PMC7703233.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    55. Altruism: Scoping review of the literature and future directions for HIV cure-related research. J Virus Erad. 2020 Nov; 6(4):100008. Dubé K, Perry KE, Mathur K, Lo M, Javadi SS, Patel H, Concha-Garcia S, Taylor J, Kaytes A, Dee L, Campbell D, Kanazawa J, Smith D, Gianella S, Auerbach JD, Saberi P, Sauceda JA. PMID: 33294210; PMCID: PMC7695811.
      View in: PubMed   Mentions: 4  
    56. Perceptions of Next-of-Kin/Loved Ones About Last Gift Rapid Research Autopsy Study Enrolling People with HIV/AIDS at the End of Life: A Qualitative Interview Study. AIDS Res Hum Retroviruses. 2020 12; 36(12):1033-1046. Dubé K, Patel H, Concha-Garcia S, Perry KE, Mathur K, Javadi SS, Taylor J, Kaytes A, Brown B, Sauceda JA, Little S, Hendrickx S, Rawlings SA, Smith DM, Gianella S. PMID: 32449624; PMCID: PMC7703245.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    57. "My Death Will Not [Be] in Vain": Testimonials from Last Gift Rapid Research Autopsy Study Participants Living with HIV at the End of Life. AIDS Res Hum Retroviruses. 2020 12; 36(12):1071-1082. Perry KE, Dubé K, Concha-Garcia S, Patel H, Kaytes A, Taylor J, Javadi SS, Mathur K, Lo M, Brown B, Sauceda JA, Wohl DA, Little S, Hendrickx S, Rawlings SA, Smith DM, Gianella S. PMID: 32449625; PMCID: PMC7703253.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    58. Perceptions of HIV Virologic Control Strategies Among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey. AIDS Res Hum Retroviruses. 2020 07; 36(7):606-615. Saberi P, Eskaf S, Sauceda J, Evans D, Dubé K. PMID: 32368934; PMCID: PMC7398435.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    59. Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading. J Virus Erad. 2020 Apr 30; 6(2):81-84. Dubé K, Dee L. PMID: 32405426; PMCID: PMC7213068.
      View in: PubMed   Mentions: 6  
    60. Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366. AIDS Res Hum Retroviruses. 2020 04; 36(4):268-282. Dubé K, Hosey L, Starr K, Barr L, Evans D, Hoffman E, Campbell DM, Simoni J, Sugarman J, Sauceda J, Brown B, Diepstra KL, Godfrey C, Kuritzkes DR, Wohl DA, Gandhi R, Scully E. PMID: 32160755; PMCID: PMC7185351.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    61. What lessons it might teach us? Community engagement in HIV research. Curr Opin HIV AIDS. 2020 03; 15(2):142-149. Karris MY, Dubé K, Moore AA. PMID: 31895141; PMCID: PMC7374765.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    62. A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption. J Virus Erad. 2020 Feb 20; 6(1):34-37. Peluso MJ, Dee L, Campbell D, Taylor J, Hoh R, Rutishauser RL, Sauceda J, Deeks SG, Dubé K. PMID: 32175090; PMCID: PMC7043899.
      View in: PubMed   Mentions: 14  
    63. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2020 04; 36(4):324-348. Dubé K, Eskaf S, Evans D, Sauceda J, Saberi P, Brown B, Averitt D, Martel K, Meija M, Campbell D, Barr L, Kanazawa J, Perry K, Patel H, Luter S, Poteat T, Auerbach JD, Wohl DA. PMID: 31608651; PMCID: PMC7185332.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    64. Applying the Behavioural and Social Sciences Research (BSSR) Functional Framework to HIV Cure Research. J Int AIDS Soc. 2019 10; 22(10):e25404. Dubé K, Auerbach JD, Stirratt MJ, Gaist P. PMID: 31665568; PMCID: PMC6820877.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    65. Secondary HIV Infection and Mitigation in Cure-Related HIV Trials During Analytical Treatment Interruptions. J Infect Dis. 2019 08 30; 220(7):1230-1231. Dee L, Boone CA, Palm D, Campbell D, Dubé K. PMID: 31505661; PMCID: PMC7325328.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    66. Factors Associated With Payments to Research Participants: A Review of Sociobehavioral Studies at a Large Southern California Research University. J Empir Res Hum Res Ethics. 2019 10; 14(4):408-415. Brown B, Marg L, Zhang Z, Kuzmanovic D, Dubé K, Galea J. PMID: 31432735.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    67. Acceptability of Cell and Gene Therapy for Curing HIV Infection Among People Living with HIV in the Northwestern United States: A Qualitative Study. AIDS Res Hum Retroviruses. 2019 07; 35(7):649-659. Dubé K, Simoni J, Louella M, Sylla L, Mohamed ZH, Patel H, Luter S, Collier AC. PMID: 30990052; PMCID: PMC6602097.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    68. Michael's Testimonial. Ann Intern Med. 2019 04 02; 170(7):511-512. Danielson MM, Dubé K. PMID: 30934078.
      View in: PubMed   Mentions: 1     Fields:    
    69. Revisiting the 'sterilising cure' terminology: a call for more patient-centred perspectives on HIV cure-related research. J Virus Erad. 2019 Apr 01; 5(2):122-124. Newton L, Necochea R, Palm D, Taylor J, Barr L, Patel H, Nathan A, Gerrard J, Sylla L, Brown B, Dubé K. PMID: 31191916; PMCID: PMC6543486.
      View in: PubMed   Mentions: 4  
    70. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting. Lancet HIV. 2019 04; 6(4):e259-e268. Julg B, Dee L, Ananworanich J, Barouch DH, Bar K, Caskey M, Colby DJ, Dawson L, Dong KL, Dubé K, Eron J, Frater J, Gandhi RT, Geleziunas R, Goulder P, Hanna GJ, Jefferys R, Johnston R, Kuritzkes D, Li JZ, Likhitwonnawut U, van Lunzen J, Martinez-Picado J, Miller V, Montaner LJ, Nixon DF, Palm D, Pantaleo G, Peay H, Persaud D, Salzwedel J, Salzwedel K, Schacker T, Sheikh V, Søgaard OS, Spudich S, Stephenson K, Sugarman J, Taylor J, Tebas P, Tiemessen CT, Tressler R, Weiss CD, Zheng L, Robb ML, Michael NL, Mellors JW, Deeks SG, Walker BD. PMID: 30885693; PMCID: PMC6688772.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    71. Putting participants at the centre of HIV cure research. Lancet HIV. 2019 03; 6(3):e147-e149. Dubé K, Barr L, Palm D, Brown B, Taylor J. PMID: 30772419.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    72. Stigma and Ebola survivorship in Liberia: Results from a longitudinal cohort study. PLoS One. 2018; 13(11):e0206595. Overholt L, Wohl DA, Fischer WA, Westreich D, Tozay S, Reeves E, Pewu K, Adjasso D, Hoover D, Merenbloom C, Johnson H, Williams G, Conneh T, Diggs J, Buller A, McMillian D, Hawks D, Dube K, Brown J. PMID: 30485311; PMCID: PMC6261413.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    73. Ethical considerations for HIV cure-related research at the end of life. BMC Med Ethics. 2018 10 20; 19(1):83. Dubé K, Gianella S, Concha-Garcia S, Little SJ, Kaytes A, Taylor J, Mathur K, Javadi S, Nathan A, Patel H, Luter S, Philpott-Jones S, Brown B, Smith D. PMID: 30342507; PMCID: PMC6196016.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    74. Michael's Testimonial. Ann Intern Med. 2018 09 04; 169(5):349. Danielson MM, Dubé K. PMID: 30178018.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    75. Assessment of the Right-to-Try Law: The Pros and the Cons. J Nucl Med. 2018 10; 59(10):1492-1493. Brown B, Ortiz C, Dubé K. PMID: 30097502.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    76. Willingness to participate in HIV research at the end of life (EOL). PLoS One. 2018; 13(7):e0199670. Prakash K, Gianella S, Dubé K, Taylor J, Lee G, Smith DM. PMID: 30036365; PMCID: PMC6056048.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    77. The Need to Track Payment Incentives to Participate in HIV Research. IRB. 2018 Jul-Aug; 40(4):8-12. Brown B, Galea JT, Dubé K, Davidson P, Khoshnood K, Holtzman L, Marg L, Taylor J. PMID: 30387975.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    78. Use of 'eradication' in HIV cure-related research: a public health debate. BMC Public Health. 2018 02 13; 18(1):245. Dubé K, Luter S, Lesnar B, Newton L, Galea J, Brown B, Gianella S. PMID: 29439706; PMCID: PMC5812044.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    79. If We Build It, Will They Come? Perceptions of HIV Cure-Related Research by People Living with HIV in Four U.S. Cities: A Qualitative Focus Group Study. AIDS Res Hum Retroviruses. 2018 01; 34(1):56-66. Sylla L, Evans D, Taylor J, Gilbertson A, Palm D, Auerbach JD, Dubé K. PMID: 29198134; PMCID: PMC5771509.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    80. Research on HIV cure: Mapping the ethics landscape. PLoS Med. 2017 Dec; 14(12):e1002470. Dubé K, Sylla L, Dee L, Taylor J, Evans D, Bruton CD, Gilberston A, Gralinski L, Brown B, Skinner A, Weiner BJ, Greene SB, Corneli A, Adimora AA, Tucker JD, Rennie S. PMID: 29220353; PMCID: PMC5722280.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    81. Reply to Commentary: "Are HIV-Infected Candidates for Participation in Risky Cure-Related Studies Otherwise Healthy?" J Empir Res Hum Res Ethics. 2018 02; 13(1):23-25. Dubé K, Sylla L, Dee L. PMID: 29179626.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    82. Crucial but understudied: incentives in HIV research. Lancet HIV. 2018 02; 5(2):e61-e62. Brown B, Galea JT, Dubé K. PMID: 29170029.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    83. Perceptions of Equipoise, Risk-Benefit Ratios, and "Otherwise Healthy Volunteers" in the Context of Early-Phase HIV Cure Research in the United States: A Qualitative Inquiry. J Empir Res Hum Res Ethics. 2018 02; 13(1):3-17. Dubé K, Dee L, Evans D, Sylla L, Taylor J, Brown B, Miller V, Corneli A, Skinner A, Greene SB, Tucker JD, Rennie S. PMID: 28984168; PMCID: PMC5768449.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    84. Ebola Virus Ribonucleic Acid Detection in Semen More Than Two Years After Resolution of Acute Ebola Virus Infection. Open Forum Infect Dis. 2017; 4(3):ofx155. Fischer WA, Brown J, Wohl DA, Loftis AJ, Tozay S, Reeves E, Pewu K, Gorvego G, Quellie S, Cunningham CK, Merenbloom C, Napravnik S, Dube K, Adjasoo D, Jones E, Bonarwolo K, Hoover D. PMID: 29670927; PMCID: PMC5897835.
      View in: PubMed   Mentions: 25  
    85. "We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry. AIDS Res Hum Retroviruses. 2018 01; 34(1):67-79. Dubé K, Evans D, Dee L, Sylla L, Taylor J, Skinner A, Weiner BJ, Greene SB, Rennie S, Tucker JD. PMID: 28562069; PMCID: PMC5771546.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    86. Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations. J Virus Erad. 2017 Apr 01; 3(2):82-84. Garner SA, Rennie S, Ananworanich J, Dube K, Margolis DM, Sugarman J, Tressler R, Gilbertson A, Dawson L. PMID: 28435691; PMCID: PMC5384270.
      View in: PubMed   Mentions: 35  
    87. Validation of the Cepheid GeneXpert for Detecting Ebola Virus in Semen. J Infect Dis. 2017 Feb 01; 215(3):344-350. Loftis AJ, Quellie S, Chason K, Sumo E, Toukolon M, Otieno Y, Ellerbrok H, Hobbs MM, Hoover D, Dube K, Wohl DA, Fischer WA. PMID: 27932614; PMCID: PMC5965086.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    88. 'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States. PLoS One. 2017; 12(1):e0170112. Dubé K, Taylor J, Sylla L, Evans D, Dee L, Burton A, Willenberg L, Rennie S, Skinner A, Tucker JD, Weiner BJ, Greene SB. PMID: 28122027; PMCID: PMC5266311.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    89. Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US. J Virus Erad. 2017 Jan 01; 3(1):40-50.e21. Dubé K, Evans D, Sylla L, Taylor J, Weiner BJ, Skinner A, Thirumurthy H, Tucker JD, Rennie S, Greene SB. PMID: 28275457; PMCID: PMC5337420.
      View in: PubMed   Mentions: 41  
    90. Towards Multidisciplinary HIV-Cure Research: Integrating Social Science with Biomedical Research. Trends Microbiol. 2016 Jan; 24(1):5-11. Grossman CI, Ross AL, Auerbach JD, Ananworanich J, Dubé K, Tucker JD, Noseda V, Possas C, Rausch DM, International AIDS Society (IAS) ‘Towards an HIV Cure’ initiative. PMID: 26642901; PMCID: PMC4698010.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    91. Participation in HIV cure-related research: a scoping review of the proxy literature and implications for future research. J Virus Erad. 2015 Oct; 1:250-256. Dubé K, Ramirez C, Handibode J, Taylor J, Skinner A, Greene S, Tucker JD. PMID: 26866059; PMCID: PMC4745088.
      View in: PubMed   Mentions: 11  
    92. How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs? Curr Opin HIV AIDS. 2015 Jan; 10(1):18-28. Ananworanich J, Dubé K, Chomont N. PMID: 25415421; PMCID: PMC4271317.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    93. Framing expectations in early HIV cure research. Trends Microbiol. 2014 Oct; 22(10):547-9. Dubé K, Henderson GE, Margolis DM. PMID: 25280965; PMCID: PMC4201845.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    94. HIV prevalence and incidence in a cohort of women at higher risk for HIV acquisition in Chókwè, southern Mozambique. PLoS One. 2014; 9(5):e97547. Feldblum PJ, Enosse S, Dubé K, Arnaldo P, Muluana C, Banze R, Nhanala A, Cunaca J, Chen PL, Robb ML, Thompson R. PMID: 24842811; PMCID: PMC4026130.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    95. Continuous compared with cyclic use of oral contraceptive pills in the Dominican Republic: a randomized controlled trial. Obstet Gynecol. 2014 May; 123(5):1012-1022. Nanda K, Lendvay A, Kwok C, Tolley E, Dubé K, Brache V. PMID: 24785854.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    96. Prevalence, incidence and determinants of herpes simplex virus type 2 infection among HIV-seronegative women at high-risk of HIV infection: a prospective study in Beira, Mozambique. PLoS One. 2014; 9(2):e89705. Meque I, Dubé K, Feldblum PJ, Clements AC, Zango A, Cumbe F, Chen PL, Ferro JJ, van de Wijgert JH. PMID: 24586973; PMCID: PMC3933639.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    97. HIV incidence in a cohort of women at higher risk in Beira, Mozambique: prospective study 2009-2012. PLoS One. 2014; 9(1):e84979. Dubé K, Zango A, van de Wijgert J, Meque I, Ferro JJ, Cumbe F, Chen PL, Ma S, Jolles E, Fumo A, Robb ML, Feldblum PJ. PMID: 24475035; PMCID: PMC3903474.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    98. Willingness to participate in future HIV prevention trials in Beira, Mozambique. Afr J AIDS Res. 2014; 13(4):393-8. Meque I, Dubé K, Bierhuizen L, Zango A, Veldhuijzen N, Cumbe F, Feldblum PJ, van de Wijgert J. PMID: 25555105.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    99. Nevirapine-based antiretroviral therapy does not reduce oral contraceptive effectiveness. AIDS. 2013 Oct; 27 Suppl 1:S17-25. Nanda K, Delany-Moretlwe S, Dubé K, Lendvay A, Kwok C, Molife L, Nakubulwa S, Edward VA, Mpairwe B, Mirembe FM. PMID: 24088680.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    100. Determinants of prevalent HIV infection and late HIV diagnosis among young women with two or more sexual partners in Beira, Mozambique. PLoS One. 2013; 8(5):e63427. Zango A, Dubé K, Kelbert S, Meque I, Cumbe F, Chen PL, Ferro JJ, Feldblum PJ, van de Wijgert J. PMID: 23691046; PMCID: PMC3656941.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    Karine's Networks
    Concepts (194)
    Derived automatically from this person's publications.
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _